-
Signature
-
Jack W. Callicutt
-
Issuer symbol
-
GALT
-
Transactions as of
-
16 Jan 2026
-
Net transactions value
-
$0
-
Form type
-
4
-
Filing time
-
21 Jan 2026, 16:50:15 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Jamil Khurram |
Chief Medical Officer |
4960 PEACHTREE INDUSTRIAL BLVD, SUITE 240, NORCROSS |
Jack W. Callicutt |
21 Jan 2026 |
0002032345 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
GALT |
Stock option (right to buy) |
Award |
$0 |
+65,000 |
|
$0.000000 |
65,000 |
16 Jan 2026 |
Common Stock |
65,000 |
$3.04 |
Direct |
F1, F2 |
| transaction |
GALT |
Restricted Stock Unit |
Award |
$0 |
+100,000 |
|
$0.000000 |
100,000 |
16 Jan 2026 |
Common Stock |
100,000 |
|
Direct |
F1, F3, F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: